5A2-SC8
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
IC8 is an ionizable cationic lipid. It has been used in combination with other lipids for the formation of lipid nanoparticles (LNPs). Immunization with severe acute respiratory coronavirus 2 (SARS-CoV-2) spike glycoprotein mRNA in IC8- and manganese-containing LNPs induces IgG responses to SARS-CoV-2 Delta and Omicron variants in mice.1 Administration of mRNA encoding B7-H3 X CD3 bispecific T cell engaging (BiTE) antibodies in IC8-containing LNPs reduces tumor growth in MV4-11 and A375 mouse xenograft models.
Research category: Ionizable lipids for in vivo T-cell engager
IC8 LNPs delivered B7H3/CD3 BiTE-encoding mRNA, with in vivo antibody expression and antitumor experiments in mouse xenograft models. Route: Intravenous.
| CAS No. | 2349307-32-8 |
| Chemical Name | IC-8(lipid MIC5) |
| Synonyms | 1,1',1'',1'''-((piperazine-1,4-diylbis(propane-3,1-diyl))bis(azanetriyl))tetrakis(tetradecan-2-ol),IC8, IC 8 |
| SMILES | OC(CCCCCCCCCCCC)CN(CC(CCCCCCCCCCCC)O)CCCN1CCN(CCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)CC1 |
| Formula | C66H136N4O4 |
| M.Wt | 1,049.8 |
| Purity | ELSD-HPLC>95% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | 1. Fan, N., Chen, K., Zhu, R., et al. Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants. Sci. Adv. 8(51), eabq3500 (2022). 2. Huang, C., Duan, X., Wang, J., et al. Lipid nanoparticle delivery system for mRNA encoding B7H3-redirected bispecific antibody displays potent antitumor effects on malignant tumors. Adv. Sci. (Weinh) |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 9.5256 mL | 1.9051 mL | 952.56 μL |
| 25 mg | 23.8141 mL | 4.7628 mL | 2.3814 mL |
| 50 mg | 47.6281 mL | 9.5256 mL | 4.7628 mL |
| 100 mg | 95.2562 mL | 19.0512 mL | 9.5256 mL |
| 250 mg | 238.1406 mL | 47.6281 mL | 23.8141 mL |
Contact our team with the catalog number and requested quantity.